Company: G
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001398659-25-000059
Chunk: 30

Company: Genpact LTD
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 30
---
,000,000 authorized, 174,661,943 and 174,870,928 issued and outstanding as of December 31, 2024 and March 31, 2025, respectively1,740 1,742 Additional paid-in capital1,945,261 1,941,478 Retained earnings1,236,696 1,274,790 Accumulated other comprehensive income (loss)(794,086)(764,949)Total equity$2,389,611 $2,453,061 Commitments and contingencies22Total liabilities and equity$4,987,153 $4,894,958 

 See accompanying notes to the Consolidated Financial Statements.

3

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data and share count)

Three months ended March 31,Notes20242025Net revenues18$1,131,237 $1,214,926 Cost of revenue734,759 785,932 Gross profit$396,478 $428,994 Operating expenses:Selling, general and administrative expenses235,031 241,084 Amortization of acquired intangible assets86,927 4,320 Other operating (income) expense, net19(5,466)(112)Income from operations $159,986 $183,702 Foreign exchange gains, net837 1,289 Interest income (expense), net20(10,242)(11,446)Other income (expense), net5,787 1,678 Income before income tax expense$156,368 $175,223 Income tax expense2139,421 44,370 Net income$116,947 $130,853 Earnings per common share16Basic$0.65 $0.75 Diluted$0.64 $0.73 Weighted average number of common shares used in computing earnings per common share16Basic180,416,537 175,528,308 Diluted181,937,555 178,435,142     

See accompanying notes to the Consolidated Financial Statements.    

4

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Comprehensive Income (Loss)

(Unaudited)

(In thousands)

 Three months ended March 31,20242025Net income$116